Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
Original Article
M. Campone, M.D. Laurentiis, K. Jhaveri, X. Hu, S. Ladoire, A. Patsouris, C. Zamagni, J. Cui, M. Cazzaniga, T. Cil, K.J. Jerzak, C. Fuentes, T. Yoshinami, A. Rodriguez-Lescure, A. Sezer, A. Fontana, V. Guarneri, A. Molckovsky, M.-A. Mouret-Reynier, U. Demirci, Y. Zhang, O. Valota, D.R. Lu, M. Martignoni, J. Parameswaran, X. Zhi, and E.P. Hamilton
N Engl J Med 2025;393:556-568
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
08/06/2025
Course expires:
08/07/2027
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward